Prenatal diethylstilbestrol exposure and reproductive hormones in premenopausal women

Journal of Developmental Origins of Health and Disease

Volumn 6, Issue 3, 2015, Pages 208-216

  Wise, L A ^a,b   Troisi, R ^c   Hatch, E E ^b   Titus, L J ^d   Rothman, K J ^b,e   Harlow, B L ^f  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e RTI HEALTH SOLUTIONS   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

diethylstilbestrol; endocrine disrupting chemicals; estrogens; females; hormones

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; FOLLITROPIN; HORMONE; INHIBIN; INHIBIN B; LUTEINIZING HORMONE;

ADULT; BLOOD; FEMALE; HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE; STATISTICAL MODEL; UNITED STATES;

ADULT; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; INHIBINS; LINEAR MODELS; LONGITUDINAL STUDIES; LUTEINIZING HORMONE; MASSACHUSETTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84929703972     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174415000082     Document Type: Article

References (41)

1. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Eng J Med. 1971; 284, 878-881.
2. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol. 1982; 142, 905-921.
3. Beral V, Colwell L. Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers. Br Med J. 1980; 281, 1098-1101.
4. Kaufman RH, Adam E, Hatch EE, et al. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000; 96, 483-489.
5. Palmer JR, Hatch EE, Rao RS, et al. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001; 154, 316-321.
6. Hatch EE, Troisi R, Wise LA, et al. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006; 164, 682-688.
7. Assies J. Hyperprolactinemia in diethylstilboestrol-exposed women (Letter). Lancet. 1991; 337, 983.
8. Peress MR, Tsai CC, Mathur RS, Williamson HO. Hirsutism and menstrual patterns in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol. 1982; 144, 135-139.
9. Wu CH,Mangan CE, Burtnett MM, Mikhail G. Plasma hormones in DES-exposed females. Obstet Gynecol. 1980; 55, 157-162.
10. Haney AF, Newbold RR, McLachlan JA. Prenatal diethylstilbestrol exposure in the mouse: effects on ovarian histology and steroidogenesis in vitro. Biol Reprod. 1984; 30, 471-478.
11. Fuller GB, Yates DE, Helton ED, Hobson WC. Diethylstilbestrol reversal of gonadotropin patterns in infant rhesus monkeys. J Steroid Biochem. 1981; 15, 497-500.
12. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry. 1999; 56, 418-424.
13. Harlow BL, Cohen LS, Otto MW, et al. Demographic, family, and occupational characteristics associated with major depression: the Harvard study of moods and cycles. Acta Psychiatr Scand. 2002; 105, 209-217.
14. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977; 1, 385-401.
15. Lucero J, Harlow BL, Barbieri RL, Sluss P, Cramer DW. Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use. Fertil Steril. 2001; 76, 723-729.
16. Lambert-Messerlian GM, Harlow BL. The influence of depression, body mass index, and smoking on serum inhibin B levels in late reproductive-aged women. J Clin Endocrinol Metab. 2006; 91, 1496-1500.
17. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin b throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996; 81, 1401-1405.
18. Diamandi A, Krishna RG, Bodani U, Mistry J, Khosravi J. A direct ELISA for human inhibin B in serum. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, 602pp.
19. Harlow BL,Wise LA, OttoMW, Soares C, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry. 2003; 60, 29-36.
20. Li R, Hertzmark E, Spiegelman D. The SAS GLMCURV9 Macro, 2008. Channing Laboratory: Boston, MA.
21. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004; 159, 702-706.
22. Zhou XH, Eckert GJ, Tierney WM. Multiple imputation in public health research. Stat Med. 2001; 20, 1541-1549.
23. SAS Institute Inc. SAS/STAT® 9.2 User's Guide, 2008. SAS Institute Inc: Cary, NC.
24. Lobo RA. Menopause: Biology and Pathobiology, 3rd edn, 2007. Academic Press: San Diego, CA.
25. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006; 12, 685-718.
26. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab. 1999; 84, 105-111.
27. Burger HG, Cahir N, Robertson DM, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf). 1998; 48, 809-813.
28. Fawzy M, Lambert A, Harrison RF, et al. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum Reprod. 2002; 17, 1535-1543.
29. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin A by FSH and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab. 2001; 86, 300-306.
30. Seifer DB, Lambert-Messerlian G, Hogan JW, et al. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril. 1997; 67, 110-114.
31. Hall JE, Welt CK, Cramer DW, Inhibin A. and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999; 14, 409-415.
32. Eldar-Geva T, Robertson DM, Cahir N, et al. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant folliclestimulating hormone. J Clin EndocrinolMetab. 2000; 85, 607-613.
33. Longcope C, Franz C, Morello C, Baker R, Johnston CC Jr. Steroid and gonadotropin levels in women during the perimenopausal years. Maturitas. 1986; 8, 189-196.
34. Longcope C, Johnston CC. Androgen and estrogen dynamics in pre-and postmenopausal women: a comparison between smokers and nonsmokers. J Clin Endocrinol Metab. 1988; 67, 379-383.
35. Palmer JR, Wise LA, Hatch EE, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15, 1509-1514.
36. Kristensen P. Bias from nondifferential but dependent misclassification of exposure and outcome. Epidemiology. 1992; 3, 210-215.
37. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995; 142, 1255-1264.
38. Steiner AZ, Baird DD, Kesner JS. Mother's menopausal age is associated with her daughter's early follicular phase urinary follicle-stimulating hormone level. Menopause. 2008; 15, 940-944.
39. van Asselt KM, Kok HS, Pearson PL, et al. Heritability of menopausal age in mothers and daughters. Fertil Steril. 2004; 82, 1348-1351.
40. Hoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011; 365, 1304-1314.
41. Smith GV, Smith OW. Prophylactic hormone therapy; relation to complications of pregnancy. Obstet Gynecol. 1954; 4, 129-141.